These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17663923)

  • 1. Monoclonal antibodies in pediatrics: use in prevention and treatment.
    Martin-Mateos MA
    Allergol Immunopathol (Madr); 2007; 35(4):145-50. PubMed ID: 17663923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-IgE monoclonal antibody (omalizumab) in the treatment of atopic asthma and allergic respiratory diseases.
    D'Amato G; Liccardi G; Noschese P; Salzillo A; D'Amato M; Cazzola M
    Curr Drug Targets Inflamm Allergy; 2004 Sep; 3(3):227-9. PubMed ID: 15379589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of asthma following severe respiratory syncytial virus (RSV) bronchiolitis in early childhood.
    Lu S; Hartert TV; Everard ML; Giezek H; Nelsen L; Mehta A; Patel H; Knorr B; Reiss TF
    Pediatr Pulmonol; 2016 Dec; 51(12):1382-1392. PubMed ID: 27152482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the treatment and prevention of severe viral bronchiolitis.
    Domachowske JB; Rosenberg HF
    Pediatr Ann; 2005 Jan; 34(1):35-41. PubMed ID: 15693214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of respiratory syncytial virus infections: indications for the use of palivizumab and update on the use of RSV-IGIV. American Academy of Pediatrics Committee on Infectious Diseases and Committee of Fetus and Newborn.
    Pediatrics; 1998 Nov; 102(5):1211-6. PubMed ID: 9794957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RSV infection and bronchiolitis: who qualifies for prevention?
    Prescrire Int; 2000 Dec; 9(50):173. PubMed ID: 11475495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal Antibodies: A Review.
    Singh S; Kumar NK; Dwiwedi P; Charan J; Kaur R; Sidhu P; Chugh VK
    Curr Clin Pharmacol; 2018; 13(2):85-99. PubMed ID: 28799485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory syncytial virus: how, why and what to do.
    Rodriguez R; Ramilo O
    J Infect; 2014 Jan; 68 Suppl 1():S115-8. PubMed ID: 24171820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory syncytial virus disease: update on treatment and prevention.
    Krilov LR
    Expert Rev Anti Infect Ther; 2011 Jan; 9(1):27-32. PubMed ID: 21171875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omalizumab : other indications and unanswered questions.
    Mankad VS; Burks AW
    Clin Rev Allergy Immunol; 2005 Aug; 29(1):17-30. PubMed ID: 16222081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies in human organ transplantation and auto-immune diseases.
    Wijdenes J; Roy C; Morel-Fourrier B; Racadot E
    Therapie; 1992; 47(4):283-7. PubMed ID: 1494788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omalizumab: anti-IgE monoclonal antibody E25, E25, humanised anti-IgE MAb, IGE 025, monoclonal antibody E25, Olizumab, Xolair, rhuMAb-E25.
    BioDrugs; 2002; 16(5):380-6. PubMed ID: 12408744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive monoclonal antibodies: current and next generation.
    Focosi D; Maggi F; Pistello M; Boggi U; Scatena F
    Clin Microbiol Infect; 2011 Dec; 17(12):1759-68. PubMed ID: 21995285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-IgE monoclonal antibody: a new approach to the treatment of allergic respiratory diseases.
    D'Amato G; Oldani V; Donner CF
    Monaldi Arch Chest Dis; 2003; 59(1):25-9. PubMed ID: 14533279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current news about epidemiology of syncytial respiratory virus infection].
    Palumbo E
    Recenti Prog Med; 2008 May; 99(5):237-9. PubMed ID: 18581965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High risk for RSV bronchiolitis in late preterms and selected infants affected by rare disorders: a dilemma of specific prevention.
    Manzoni P; Paes B; Resch B; Carbonell-Estrany X; Bont L
    Early Hum Dev; 2012 May; 88 Suppl 2():S34-41. PubMed ID: 22633511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between respiratory syncytial virus infection and reactive airway disease.
    Piedimonte G
    Respir Med; 2002 Apr; 96 Suppl B():S25-9. PubMed ID: 11996401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RSV disease--is there a role for prevention?
    Lenney W
    Respir Med; 2001 Mar; 95(3):170-2. PubMed ID: 11266232
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.
    Holgate ST; Djukanović R; Casale T; Bousquet J
    Clin Exp Allergy; 2005 Apr; 35(4):408-16. PubMed ID: 15836747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Tac (daclizumab, Zenapax) in the treatment of leukemia, autoimmune diseases, and in the prevention of allograft rejection: a 25-year personal odyssey.
    Waldmann TA
    J Clin Immunol; 2007 Jan; 27(1):1-18. PubMed ID: 17216565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.